Genzyme Experts Discuss Gaucher Disease

Published: Saturday, Jan 14, 2012

Richard Moscicki, MD, the head of Clinical Development and Rogério Vivaldi, MD, the Head of Rare Diseases at Genzyme Corporation share their unique perspectives on the history of Gaucher disease.

Richard Moscicki, MD, the head of Clinical Development and Rogério Vivaldi, MD, the Head of Rare Diseases at Genzyme Corporation share their unique perspectives on the history of Gaucher disease.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Medical Crossfire®: Clinical Updates on PARP Inhibition and its Evolving Use in the Treatment of CancersMay 30, 20181.5
Publication Bottom Border
Border Publication
x